Search results
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 4 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck KGaA (ETR:MRK) Is Due To Pay A Dividend Of €2.20
Simply Wall St. via Yahoo Finance· 21 hours agoThe board of Merck KGaA (ETR:MRK) has announced that it will pay a dividend of €2.20 per share on...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 3 days agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 2 days agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 3 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 4 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 4 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 3 days agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...
Merck&Co earnings beat by $0.14, revenue topped estimates
Investing.com· 4 days agoMerck&Co earnings beat by $0.14, revenue topped estimates